Thromb Haemost 1986; 56(01): 057-062
DOI: 10.1055/s-0038-1661603
Original Article
Schattauer GmbH Stuttgart

In Vitro Incorporation and Metabolism of Icosapentaenoic and Docosahexaenoic Acids in Human Platelets - Effect on Aggregation

Martine Croset
The INSERM U63, Institut Pasteur and Laboratoire d’Hémobiologie, Faculté de Medecine Alexis Carrel, Lyon, France
,
M Lagarde
The INSERM U63, Institut Pasteur and Laboratoire d’Hémobiologie, Faculté de Medecine Alexis Carrel, Lyon, France
› Author Affiliations
Further Information

Publication History

Received 30 December 1985

Accepted 26 May 1986

Publication Date:
13 July 2018 (online)

Summary

Washed human platelets were pre-loaded with icosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or EPA + DHA and tested for their aggregation response in comparison with control platelets. In fatty acid-rich platelets, an inhibition of the aggregation could be observed when induced by thrombin, collagen or U-46619. The strongest inhibition was observed with DHA-rich platelets and it was reduced when DHA was incorporated in the presence of EPA.

Study of fatty acid distribution in cell lipids after loading showed that around 90% of EPA or DHA taken up was acylated into phospholipids and a very small amount (less than 2%) remained in their free and hydroxylated forms. DHA was more efficiently acylated into phosphatidylethanolamine (PE) than into phosphatidylinositol (PI) in contrast to what observed with EPA, and both acids were preferentially incorporated into phosphatidylcholine (PC). EPA inhibited total incorporation of DHA and increased its relative acylation into PE at the expense of PC. In contrast, DHA did not affect the acylation of EPA. Upon stimulation with, thrombin, EPA was liberated from phospholipids and oxygenated (as judged by the formation of its monohydroxy derivative) whereas DHA was much less metabolized, although consistently transferred into PE.

It is concluded that EPA and DHA might affect platelet aggregation via different mechanisms when pre-loaded in phospholipids. Whereas EPA is known to alter thromboxane A2 metabolism from endogenous arachidonic acid, by competing with it, DHA might act directly at the membrane level for inhibiting aggregation.

 
  • References

  • 1 Dyerberg J, Bang HO. Haemostasis function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1978; 11: 152
  • 2 Dyerberg J, Bang HO. Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the PG-3 family. Haemostasis 1979; 8: 227-223
  • 3 Sanders TAB, Naismith DJ, Haines AP, Vickers M. Cod liver oil, platelet fatty acids, and bleeding time. Lancet 1980; 1: 1189
  • 4 Siess W, Scherer B, Bohling B, Roth P, Kurzmann I, Weber PC. Platelet membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1980; 1: 441-444
  • 5 Bradlow BA, Chetty N, Van der Westhuyzen J, Mendelsohn D, Gibson JE. The effects of a mixed fish diet on platelet function, fatty acids and serum lipids. Thromb Res 1983; 29: 561-568
  • 6 Thorngren M, Shafi S, Born G VR. Delay in primary haemostasis produced by a fish diet without change in local TXA2. Brit J Haemat 1984; 58: 567-578
  • 7 Fischer S, Weber PC. Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (20:5n-3). Biochem Biophys Res Commun 1983; 116: 1091-1099
  • 8 Hirai A, Terano T, Hamazaki J, Sajiki S, Kondo A, Ozawa T, Fujita T, Miyamoto Y, Tamura Y, Kumagai A. The effects of the oral administration of fish oil concentrate on the release and the metabolism of 14C-AA and 14C-20:5n-3 by human platelets. Thromb Res 1982; 28: 285-295
  • 9 Needleman P, Raz A, Minkes MJ, Ferrendelli SA, Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci 1979; 76: 944-948
  • 10 Sanders TAB, Vickers M, Haines AP. Effect on blood lipids and haemostasis of a supplement of cod liver oil, rich in eicosapentaenoic and docosahexaenoic acids in healthy young men. Clin Sci 1981; 61: 317-324
  • 11 Fischer S, Schacky CV, Siess W, Strasser Th, Weber PC. Uptake, release and metabolism of docosahexaenoic acid in human platelets and neutrophils. Biochem Biophys Res Commun 1984; 120: 907-918
  • 12 Rao G HR, Radda E, White JG. Effect of docosahexaneoic acid on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun 1983; 117: 549-555
  • 13 Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci 1983; 80: 3581-3584
  • 14 Aveldano MI, Sprecher H. Synthesis of hydroxy fatty acids from 4, 7, 10,13,16,19-[1-14C]docosahexaenoic acid by human platelets. J Biol Chem 1983; 258: 9339-9343
  • 15 Lagarde M, Bryon PA, Guichardant M, Dechavanne M. A simple and efficient method for platelet isolation from their plasma. Thromb Res 1980; 17: 581-588
  • 16 Lagarde M, Drouot B, Guichardant M, Dechavanne M. In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta 1985; 833: 52-58
  • 17 Born G VR. Observation on the change in shape of blood platelet brought by adenosine diphosphate. J Physiol 1973; 209: 487-511
  • 18 Fine JB, Sprecher H. Unidimensional thin layer chromatography of phospholipids or boric acid impregnated plates. J Lipid Res 1982; 23: 660-663
  • 19 Holme S, Brox JH, Krane H, Nordoy A. The effect of albumin bound polyunsaturated fatty acids on human platelets. Thromb Haemostas 1984; 51: 32-36
  • 20 MacIntyre DE, Hoover RL, Smith M, Steer M, Lynch C, Karnovsky MJ, Salzman EW. Inhibition of platelet function by cis-unsaturated fatty acids. Blood 1984; 63: 848-857
  • 21 Croset M, Lagarde M. Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun 1983; 112: 878-883
  • 22 Hajarine M, Lagarde M. Studies on polyenoic acids incorporation into human platelet lipid stores. Interactions with linoleic and arachidonic acids. Biochim Biophys ACTA 1986 (in press)
  • 23 Galloway JH, Cartwright IJ, Woodcock BE, Greaves M, Russel GG, Preston FE. Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipids pools. Clin Sci 1985; 68: 449-454
  • 24 Schacky CV, Siess W, Fischer S, Weber PC. A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res 1985; 26: 457-464
  • 25 Colard O, Breton M, Bereziat G. Induction by lysophospholipids of CoA-dependent arachidonyl transfer between phospholipids in rat platelets homogenates. Biochim Biophys Acta 1984; 793: 42-48
  • 26 Rittenhouse-Simmons SE, Russel FA, Deykin D. Transfer of arachidonic acid to human platelet plasmalogen in response to thrombin. Biochem Biophys Res Commun 1976; 70: 295-301
  • 27 Hornstra G, Rand ML. Effect of dietary N-6 and N-3 polyunsaturated fatty acids on the fluidity of platelet membranes in rat and man. Prog Lipid Res 1986 (In press)
  • 28 Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984; 779: 89-137